Drug Profile
Research programme: influenza vaccines - LG Chem
Latest Information Update: 17 Aug 2017
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections in South Korea (Parenteral)